NRG1-ERBB4 signaling has also been discussed as a target of gene therapy in adults with neurodevelopmental disorders to reduce cognitive impairment, e.g., in executive functions (Shi and Bergson, 2020). Here, NRG1 is linked to Cognitive impairment.